CD68 and metabolic dysfunction-associated steatohepatitis: In order to investigate whether Gal-3+ macrophage reduction in patients with NASH was ascribable to a decrease of the number of Gal-3+ M2 macrophages, we performed a triple staining for CD68, Gal-3, and CD206 (human M2 marker).